STARLIMS LIMS Technology to be Installed in FDA Testing Laboratories
News Jul 09, 2012
Abbott has announced that the Food and Drug Administration will begin implementing Abbott’s STARLIMS® software-based laboratory information management system (LIMS) as part of the agency’s initiative to enhance FDA testing laboratories.
STARLIMS LIMS software will be used to manage complex processes and the analysis of the vast amounts of information generated by FDA laboratories.
As part of a master agreement with Dovèl Technologies, a company that provides high-end software applications to government organizations, the FDA’s Office of Regulatory Affairs (ORA) will begin deploying LIMS solutions from STARLIMS, designed to enhance testing of food and drug chemistries, devices, forensics material and microbiology samples. The ORA operates mainly five types of laboratories in 14 separate locations. The LIMS solution will provide the needed capability to manage the analytical workflow operations in ORA labs for approximately 825 users supporting sample accountability, data analysis, document control, report generation, and other lab operation functions.
“We’re looking forward to working on this important initiative,” said Isaac Friedman, head of Abbott’s STARLIMS business. “STARLIMS has a successful track record in implementing web-based LIMS for life sciences organizations, public health laboratories and a number of federal agencies.”
Algorithm Enables Real-time Brain Scan RegisteringNews
Machine-learning algorithm that can register brain scans and other 3-D images more than 1,000 times more quickly using novel learning techniques.READ MORE
Biometric System Measures Brainwaves, Creates Brain PasswordNews
The “brain password” could have implications in banking, law enforcement, airport security and other areas.READ MORE
Cryo-EM Reveals Interaction Between Major Drug TargetsNews
For the first time, scientists have visualized the interaction between two critical components of the body's vast cellular communication network, a discovery that could lead to more effective medications with fewer side effects for conditions ranging from migraine to cancer.READ MORE